Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Looking Into Histogen’s Return On Capital Employed
According to data from Benzinga Pro, during Q4, Histogen's (NASDAQ:HSTO) reported sales totaled $5.00 thousand. Despite a 18.27% increase in earnings, the company posted a loss of $3.15 million.
Histogen Q4 EPS $(0.07) Beats $(0.10) Estimate, Sales $5.00K Down From $478.00K YoY
Histogen (NASDAQ:HSTO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 73.08 percent increase over losses of $(0.26) per share from the same
Earnings Preview For Histogen
Histogen (NASDAQ:HSTO) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement.
Analysts estimate that Histogen will report an earnings per share (EPS) of $-0.10.
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.